Lista de

drug selectivity
16
"Modified ribavirin analogues as antiviral agents against Junín virus" (2019) Contin, M.;Sepúlveda, C.;Fascio, M. (...)D'Accorso, N.B. Bioorganic and Medicinal Chemistry Letters. 29(4):556-559
"Selective hemangioma cell dysfunction and apoptosis triggered by in vitro treatment with imiquimod" (2018) Rocco, R.;Alegre, N.;Pozner, R. (...)Gazzaniga, S. Toxicology Letters. 288:82-88
"β-Carboline derivatives as novel antivirals for herpes simplex virus" (2018) Gonzalez, M.M.;Cabrerizo, F.M.;Baiker, A. (...)Vizoso-Pinto, M.G. International Journal of Antimicrobial Agents. 52(4):459-468
"Latest advances in OBOC peptide libraries. Improvements in screening strategies and enlarging the family from linear to cyclic libraries" (2016) Martínez-Ceron, M.C.;Giudicessi, S.L.;Saavedra, S.L. (...)Camperi, S.A. Current Pharmaceutical Biotechnology. 17(5):449-457
"Preparation, anticholinesterase activity and molecular docking of new lupane derivatives" (2014) Castro, M.J.;Richmond, V.;Romero, C. (...)Murray, A.P. Bioorganic and Medicinal Chemistry. 22(13):3341-3350
"Antimalarial activity of new acridinone derivatives" (2011) Fernández-Calienes, A.;Pellón, R.;Docampo, M. (...)Rojas, L. Biomedicine and Pharmacotherapy. 65(3):210-214
"Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives" (2010) Romanutti, C.;Bruttomesso, A.C.;Castilla, V. (...)Wachsman, M.B. Chemotherapy. 56(2):158-165
"Alpha9 nicotinic acetylcholine receptors and the treatment of pain" (2009) McIntosh, J.M.;Absalom, N.;Chebib, M. (...)Vincler, M. Biochemical Pharmacology. 78(7):693-702
"Sulfated xylomannans from the red seaweed Sebdenia polydactyla: Structural features, chemical modification and antiviral activity" (2009) Ghosh, T.;Pujol, C.A.;Damonte, E.B. (...)Ray, B. Antiviral Chemistry and Chemotherapy. 19(6):235-242
"Zn finger containing proteins as targets for the control of viral infections" (2007) García, C.C.; Damonte, E.B. Infectious Disorders - Drug Targets. 7(3):204-212
"Development of β-Lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels" (2005) Reinicke, K.E.;Bey, E.A.;Bentle, M.S. (...)Boothman, D.A. Clinical Cancer Research. 11(8):3055-3064
"Structural determinants of efficacy at A3 adenosine receptors: Modification of the ribose moiety" (2004) Gao, Z.-G.;Jeong, L.S.;Moon, H.R. (...)Jacobson, K.A. Biochemical Pharmacology. 67(5):893-901
"Antiviral activity of natural and synthetic brassinosteroids" (2004) Wachsman, M.B.;Ramírez, J.A.;Talarico, L.B. (...)Coto, C.E. Current Medicinal Chemistry: Anti-Infective Agents. 3(2):163-179
"Sulfated seaweed polysaccharides as antiviral agents" (2004) Damonte, E.B.; Matulewicz, M.C.; Cerezo, A.S. Current Medicinal Chemistry. 11(18):2399-2419
"Structure-activity relationship studies in a set of new brassinosteroid derivatives assayed against herpes simplex virus type 1 and 2 in cell cultures" (2002) Talarico, L.B.; Ramírez, J.A.; Galagovsky, L.R.; Wachsman, M.B. Medicinal Chemistry Research. 11(8):434-444
"Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds" (2000) García, C.C.; Candurra, N.A.; Damonte, E.B. Antiviral Chemistry and Chemotherapy. 11(3):231-237